Expert Pitch
University of Washington

A contact-tracing app that helps public health agencies and doesn't compromise your privacy

23-Apr-2020 8:35 AM EDT, by University of Washington

Stay-at-home orders and social distancing have been successful in some areas to help flatten the coronavirus curve. As parts of the world begin to open up again, communities need a reliable way to keep track of the virus and contain its spread. 

Contact-tracing apps may provide one option as part of a larger strategy. These apps monitor who has come in contact with whom and can, when appropriate, alert a network of people if someone nearby has been diagnosed with the virus. But many current contact-tracing apps have privacy red flags — for example leaking a user's location information or taking away people's control over their own data. 

Now researchers from the University of Washington and UW Medicine, along with volunteers from Microsoft, have developed a new tool, CovidSafe. This contact-tracing app, developed with input from public health officials and contact tracing teams, would alert people about potential exposure to COVID-19 without giving up anyone's privacy. This app could also help individuals who test positive prepare for a contact tracing interview with a public health official. 

CovidSafe is not ready to be downloaded from app stores, but an Android demo version is accessible through the team's website. Users who try the demo version, which doesn't have full functionality yet, can submit feedback to the team. This app is based off a series of privacy and security guidelines that the team outlined in a white paper posted earlier this month to the preprint site arXiv. 

"Contact tracing is one of the most effective tools that public health officials have to halt a pandemic and prevent future outbreaks," said author Justin Chan, a UW doctoral student in the Paul G. Allen School of Computer Science & Engineering. "Our contact-tracing app addresses underlying privacy, security and re-identification issues, rather than sweeping them under the rug. With CovidSafe, all information is stored locally on your phone unless you choose to share that you’ve tested positive. Only then is your data sent to a secure server, and the app alerts anyone who has been nearby. After these notifications are sent, all the information is deleted." 

CovidSafe takes several steps to maintain users' privacy. The app begins by assigning each user a secret code name, which remains private. Then it generates a variation of the code name that changes every 15 minutes and uses Bluetooth to broadcast that to other users nearby. CovidSafe also stores a list of these people's smartphone signals. With the full version of CovidSafe, if a user tests positive and they choose to share that information with the app, it will alert anyone who has come in contact with them within the past 14 days — the infection window for COVID-19 — without divulging who the person is or where they are. 

"Conventional contact tracing already requires a person to give up some measure of personal privacy as well as the privacy of those they came into contact with," said collaborator Stefano Tessaro, an associate professor in the Allen School. "However, we can make acceptable trade-offs to enable us to use the best tools available to speed up and improve that process, all while ensuring stronger privacy guarantees at the same time." 

Because not everyone will want to use a contact-tracing app, CovidSafe aims to augment — not replace — conventional contact tracing, which public health officials do by interviewing patients who've tested positive about where they have been and who they have seen. CovidSafe creates a log of users' locations over time, so it can help people in these interviews by providing them with the details about where they've been lately. 

"This is being built first and foremost with contact-tracing teams and public health officials in mind," said collaborator Dr. Jacob Sunshine, an assistant professor of anesthesiology and pain medicine at the UW School of Medicine. "They are the experts, and much of the functionality has been developed based on direct feedback from teams doing this necessary and difficult work. Combined with extremely thoughtful privacy-preserving designs, this system is built to meet the needs of a privacy-conscious public and to efficiently deliver useful information that can help public health systems and contact tracers work smarter and faster." 

CovidSafe has other features, including a symptom tracker so that users who have tested positive and are in isolation can track their symptoms, and a messaging system that will eventually allow users to receive tailored health announcements from local public health agencies. The researchers have made the code behind the app publicly available for organizations to customize for their own use. 

"Ten years from now, I want to be able to look back and genuinely say, 'I did something to help in the greatest crisis of my lifetime,'" said collaborator John Langford, one of the project volunteers who is also a computer scientist at Microsoft Research. "At this point, dozens of people have contributed hundreds of hours toward making this project happen. We have all the expertise needed to create something genuinely useful, and we are well on the way." 

Other co-authors on the white paper are Sham Kakade, Shyam Gollakota, Joseph Jaeger, Tadayoshi Kohno and Sudheesh Singanamalla in the Allen School, and Eric Horvitz and Jonathan Larson at Microsoft. 

This research was funded by the Washington Research Foundation, the Office of Naval Research, the National Science Foundation, the National Institutes of Health and the Alfred P. Sloan Foundation.

 

###

 

For more information or to submit feedback about CovidSafe, contact the team at Covidsafe@uw.edu.

 

Grant numbers: N00014-18-1-2247, #CCF 1637360, #CCF 1740551, K23DA046686, 1914873, 1812559, CNS-1553758 and CNS-1719146




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.5746